JP Morgan Chase
RAIN

JP Morgan Chase’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

JP Morgan Chase’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,220
Closed -$20.7K – 8086
2023
Q4 		$20.7K Buy
17,220
+5,753
+50% +$6.21K ﹤0.01% 6245
2023
Q3 		$9.88K Sell
11,467
-2,528
-18% -$2.77K ﹤0.01% 6262
2023
Q2 		$16.8K Buy
13,995
+13,543
+2,996% +$67.8K ﹤0.01% 5952
2023
Q1 		$4K Hold
452
– – ﹤0.01% 6320
2022
Q4 		$4K Sell
452
-235
-34% -$1.48K ﹤0.01% 6226
2022
Q3 		$3K Hold
687
– – ﹤0.01% 6212
2022
Q2 		$4K Sell
687
-8,928
-93% -$30.6K ﹤0.01% 6220
2022
Q1 		$49K Sell
9,615
-4,627
-32% -$37.1K ﹤0.01% 5809
2021
Q4 		$183K Buy
14,242
+11,393
+400% +$163K ﹤0.01% 5407
2021
Q3 		$43K Hold
2,849
– – ﹤0.01% 5882
2021
Q2 		$44K Buy
+2,849
New +$49.9K ﹤0.01% 5773

JP Morgan Chase's RAIN Position: Q1 2024 in Review

JP Morgan Chase sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 17,220 shares — an estimated $20.7K sold.

JP Morgan Chase first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $183K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • JP Morgan Chase reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 17,220 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $20.7K.
  • JP Morgan Chase first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • JP Morgan Chase's Rain Oncology Inc. Common Stock position peaked at $183K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.